Peroxisome proliferator-activated receptor-gamma (PPARγ) regulates both glucose metabolism and bone mass. Evidence suggests that the therapeutic modulation of PPARγ with synthetic agonists activity may elicit undesirable effects on bone. However, there is no information regarding its natural agonist 15d-PGJ 2 , besides its excellent anti-inflammatory action. In the present study the effects of 15d-PGJ 2 on osteoblastic cells were determined. Osteoblastic cells (MC3T3) were cultured in an osteogenic medium in the presence of 1, 3 or 10 μM of 15d-PGJ 2 during 21 days and alizarin and Von Kossa staining were employed. The protein expression (type-I collagen, osteonectin, osteopontin, RANKL, osteoprotegerin, HDAC-9c and PPAR-γ) was evaluated after 3 days in the presence of 15d-PGJ 2 by western blotting and indirect immunofluorescence methods. The production of mineralized extracellular matrix was observed by transmission electron microscopy. After 72 h of culture, the mRNA was extracted for RT-qPCR analysis of RUNX expression. In the presence of all 3 tested 15d-PGJ 2 doses, alizarin red and Von kossa staining were positive demonstrating the ability to the osteoblast differentiation. Type-I collagen and osteonectin proteins expression were up-regulated (p b 0.05) after 72 h in the presence of the smaller doses of 15d-PGJ 2 . In contrast, osteopontin, RANKL and OPG expression did not significantly alter. In the presence of 15d-PGJ 2 it was possible to visualize mineralized nodules in the extracellular matrix confirmed with the increased RUNX mRNA expression. 15d-PGJ 2 at small doses increased the osteoblast activity and the bone-related proteins expression.
Introduction
Bone is an organ that is under constantly remodeling during the lifetime conducted mainly by osteoblast, osteocytes and osteoclast cells. It is known that osteoblasts and adipocytes are closely related through a common progenitor cell [1] . Commitment of progenitor cell toward the adipocyte or osteoblast fate occurs through a highly regulated mechanism in which lineage-specific transcription factors (such as Runt-related transcription factor 2 (Runx-2) for osteoblasts and peroxisome proliferator-activated receptor-gamma (PPAR-γ) for adipocytes).
The PPAR-γ is a nuclear receptor that controls not only adipogenesis but also the endocrine function of adipose tissue [2] . Since thiazolidinediones (TZD), potent PPAR-γ ligands, have been approved for clinical use in the treatment of type II diabetes in 1999, their effects on human bone are just emerging. Clinical studies have revealed that TZD decrease markers of bone formation with reduction in bone mass and increase in fracture incidence [3] [4] [5] [6] . Thus, it has been postulated that TZDs, via PPAR-γ activation, increase adipocyte differentiation at the expense of osteoblasts in vitro [7] .
15-deoxy-Δ12, 14 -prostaglandin J 2 (15d-PGJ 2 ), a cyclopentenonetype prostaglandin with a wide spectrum of physiological activities, is one of the terminal products of the cyclooxygenase-2 (COX-2) pathway. 15d-PGJ 2 was initially discovered as an endogenous ligand for PPAR-γ with potent anti-inflammatory activities [8] [9] [10] [11] [12] [13] . However, studies have demonstrated that 15d-PGJ 2 have also PPAR-γ-independent effects such as inhibition of NF-kB translocation to the nucleus through inhibition of IkBα phosphorylation [14] . Moreover, 15d-PGJ 2 possess a potent suppressive effect on inflammatory responses of osteoblast-like cells MC3T3E-1 via the Akt and NF-κB pathways independent of PPAR-γ [15] . Besides, in a macrophage PPAR-γ knockout model, the lack of PPAR-γ had no effect on the ability of PPAR-γ agonists to block pro-inflammatory cytokine production [16] . Along with another studies in different models and approaches, it is consensus that 15d-PGJ 2 has a strong PPAR-γ-independent activity.
International Immunopharmacology 16 (2013) [131] [132] [133] [134] [135] [136] [137] [138] Thus, since PPAR-γ signaling is critical for bone homeostasis and 15d-PGJ 2 might be a promising anti-inflammatory molecule indicated by different approaches, and several of these effects are PPAR-γ-independent, we delineated this experiment to understand the influence of the 15d-PGJ 2 in the osteoblastic phenotype.
Material and methods

Cell culture
The mouse MC3T3-E1 pre-osteoblastic cells were obtained from the American Type Culture Collection (Manassas, VA, USA). The cell culture were maintained in DMEM/Ham's F-12 medium (LGC Biotechnology, São Paulo, Brazil) supplemented with 50 μg/mL ascorbic acid (Sigma, St. Louis, MO, USA) and 10 mM β-glycerolphosphate (Sigma) containing 10% fetal bovine serum and 1% antibiotics, and cultured in a humidified atmosphere of 95% air and 5% carbon dioxide at 37°C. The MC3T3-E1 cells were incubated for a total period of 72 h before all the experimental assays.
Cell proliferation and cell viability assays
Cells were grown on 24 and 96 wells plates (Corning, NY, USA) in an initial density of 110 cells/mm 2 per well, respectively for the proliferation and viability tests. After 72 h, the medium was changed and supplemented or not with 15d-PGJ 2 (Sigma-Aldrich, St. Louis, MO, USA) at 1, 3 or 10 μM doses. After 24, 48, 72 or 144 h, the cells from 3 randomly wells were detached with 0.05% trypsin and counted in Neubauer's chamber to calculate the proliferation indices. In a different set of plates, at the same conditions described, 10 μl of MTT solution (5 mg/mL in phosphate buffer saline (PBS)) plus 90 μL of base medium were added into each well. Cells were incubated for 3 h at 37°C with 5% CO 2 , 95% air and complete humidity. After 3 h, the MTT solution was removed and replaced with 100 μL of dimethyl sulfoxide. The plate was further incubated for 15 min at room temperature (RT), and the optical density (OD) of the wells was determined using a plate reader at a test wavelength of 590 nm in a SpectraMax Plus microplate reader (Molecular Devices, Sunnyvale, CA, USA). The experiments were performed at the same conditions twice for accuracy.
Alizarin red staining
In order to evaluate calcium deposits, the cells were grown on glass coverslips (~13 mm) and analyzed after 21 days. After these periods of treatment the cells were rinsed with Hanks' balanced salt solution (Sigma), fixed with 70% ethanol for 1 h at 4°C, followed by staining with 2% alizarin red S (Sigma), pH 4.2 for 15 min at RT. The alizarin red-positive nodules were examined using light microscopy (Nikon eclipse E800, Japan).
von Kossa staining
To determine the presence of phosphate-based mineral nodules, the cell cultures were grown on glass coverslips (~13 mm) and analyzed after 21 days. Thereafter, the cells were stained by applying 0.5% silver nitrate solution (Sigma) for 20 min under bright light and rinsed with distilled water. Then, they were incubated with 0.5% sodium hydroquinone (Sigma) for 2 min, followed by 5% sodium thiosulphate solution (Sigma) for 2 min. The black-stained phosphate nodules were examined using light microscopy (Nikon eclipse E800, Japan).
Transmission electron microscopy
In order to certify the production of extracellular matrix by collagen fibrils formation, cells cultured on 13 mm polystyrene coverslips (Themanox®, Thermo Scientific Nunc) were ultrastructurally analyzed after 14 days of treatment. The cells were fixed in 0.1% glutaraldehyde and 4% formaldehyde in 0.1 mol/L sodium cacodylate buffer (pH 7.4) for 1 hour at RT. They were rinsed in the same buffer and post-fixed in 1% osmium tetroxide for 1 h, dehydrated in a graded series of ethanol and acetone, and embedded in Spurr resin. Semi-thin sections were cut in a Micron HM360 microtome with glass knives made in a knife maker Leica EM KMR3 (Leica Instruments GmbH, Nussloch, Germany) and stained with 0.25% toluidine blue. Representative areas were selected for 70-nm-thick ultrathin sections by using a Leica Ultracut R ultramicrotome with a Diatome diamond knife and examined with a JEM 1010 electron microscope (Jeol USA Inc, Peabody, MA) operating at 80 kV.
Immunofluorescence
Cell grown on coverslips in different concentrations of 15d-PGJ 2 (1, 3 or 10 μM) during 72 h, were fixed in methanol for 6 min at 20°C , rinsed in PBS followed by blocking with 1% bovine albumin in PBS for 30 min at RT. The primary polyclonal antibodies used were anti-type I collagen (1:50, mouse, Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-osteonectin (1:50, rabbit, kindly supplied by Dr. Larry Fisher, NIDCR, NIH, Bethesda, USA) and anti-osteopontin (1:50, rabbit, Abcam, Cambridge, UK). Control staining reaction was performed using PBS in substitution to the primary antibody. The secondary antibody used was biotinylated anti-rabbit IgG or anti-mouse IgG (Vector Laboratories Inc, Burlingame, CA, USA). Following, fluorescein-streptavidin conjugated (Vector) was used. After washing, preparations were mounted using Vectashield DAPI-associated (4'-6-diamidino-2-phenylindole) (Vector) and observed on a Zeiss Axioskop 2 conventional fluorescence microscope (Carl Zeiss MicroImaging GmbH, Germany) equipped with 63x Plan Apochromatic 1.4NA and 100x Plan Apochromatic 1.4NA objectives in standard conditions (Carl Zeiss, Oberköchen, Germany). The immunofluorescence experiments were repeated three times for each 15d-PGJ 2 concentration tested.
Real time quantitative PCR
Cells were grown during 72 h in the presence or not of 15d-PGJ 2 (1, 3 or 10 μM) for the evaluation of the mRNA levels of Runt-related transcription factor (RUNX) and Glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Total RNA was isolated by the Trizol method (Gibco BRL, Life Technologies, Rockville, MD, USA) according to the manufacturer's recommendation. RNA samples were re-suspended in diethylpyrocarbonate-treated water and stored at −70°C. The RNA concentration was determined from the OD using a micro-volume spectrophotometer (Nanodrop 1000, Nanodrop Technologies LLC, Wilmington, NC, USA). Reverse transcription total RNA was DNase treated (Turbo DNA-frees, Ambion Inc., Austin, TX, USA), and 1 μg was used for cDNA synthesis. The reaction was carried out using the First-Strand cDNA synthesis kit (Fermentas, Glen Burnie, MD, USA), following the manufacturer's recommendations. Primers were designed using the Primer Express 3.0 probe design software (Applied Biosystem, Foster City, CA, USA). Quantitative real-time polymerase chain reaction (qPCR) was performed in the 7300 Real Time PCR (Applied Biosystem) using the SYBR Green PCR Master Mix (Fermentas). The reaction product was quantified with the Relative Quantification tool, using GAPDH as the reference gene. Negative controls with SYBR Green PCR Master Mix and water were performed for all reactions. 
Western blotting
Cells were grown during 72 h in the presence or not of 15d-PGJ 2 (1, 3 or 10 μM) then the cell lysates were prepared by homogenization at 4°C and centrifuged at 15.000 g for 15 min at 4°C. The protein concentration was measured by BCA assay (Pierce, Rockford, IL, USA). Protein extracts were separated in a 10% sodium dodecylsulfatepolyacrylamide gels, transferred onto polyvinylidene difluoride membranes (Hybond; Amersham Biosciences, Piscataway, NJ, USA), and probed for 1 hour with the primary antibodies anti-collagen-I, anti-osteopontin, anti-osteonectin, anti-Receptor activator of nuclear factor kappa-B ligand (RANKL), anti-osteoprotegerin (OPG), anti-PPAR-γ and anti-Histone deacetylase 9c (HDAC-9c) (1:1000) diluted in TBST + 5% of low fat milk. The α-tubulin primary antibody was used as an endogenous control (1:1000; Santa Cruz Biotechnology, Santa Cruz, CA). After incubation with a mouse or rabbit monoclonal secondary antibody (1:2500), the reaction was revealed with Bio-Rad Laboratories (Hercules, CA, USA) Western blotting chemiluminescent detection reagents (Opti-4CN) into x-ray films (GE Healthcare, Fairfield, CT, USA). OD measurements were made with NIH Image 1.37 (National Institutes of Health, Bethesda, MD) for scanned membranes. All experiments were made in duplicate in 3 different sets. Fold induction was calculated by normalizing relative OD values to that of the control value that was taken as 1.
Statistical analysis
To determine if there were significant differences the data was analyzed using the one-way ANOVA or two-way ANOVA. If there was a significant among-subjects main effect of treatment group following one-way ANOVA, post-hoc using the Tukey test, were performed to determine the basis of the significant difference (one-way ANOVA) or Bonferroni (two-way ANOVA). The significance level considered was lower than 5%.
Results
In order to verify the cytotoxicity of the 15d-PGJ 2 in MC3T3 cell culture, we have performed proliferation and viability cell assays in different periods and doses. Thus, stimulation by 15d-PGJ 2 with all 3 tested doses did not statistically affect the rate of cell growth (Fig. 1A) nor the cell viability (Fig. 1B) .
Next, the in vitro mineralization of the extracellular matrix protein evaluated by alizarin red (Fig. 2A, B , C, D) and von kossa (Fig. 2 E, F , G, H) staining supported the cell proliferation and viability experiments. When the cells were treated with different doses of 15d-PGJ 2 , bone-like nodules formation was identified in all studied conditions, as well as in the positive control group treated with mineralizing factors alone. Ultrastructural examination of MC3T3 cell cultures treated or not with 15d-PGJ 2 confirmed the presence of few collagen fibrils and among them some calcification nodules, corroborating the presence of mineralizing nodules was also observed in all studied doses of 15d-PGJ 2 (Fig. 3) .
The immunofluorescence expression of type I collagen (Col I), osteopontin (OPN) and osteonectin (ONEC) was detected throughout punctuate deposits throughout the cytoplasm, mainly in the perinuclear region that corresponds to the Golgi apparatus in the presence as well in the absence of 15d-PGJ 2 (Fig. 4) . This proteins expression was also semi quantitatively analyzed by Western blotting. Interesting, only the lowest doses of 15d-PGJ 2 (1 μM) induced statistical significant increase (p b 0.05) on type I collagen expression (Fig. 5A ). In addition, doses of 1 and 3 μM of 15d-PGJ 2 statistically increased (p b 0.05) the expression of osteonectin (Fig. 5B) . On the other hand, the presence of different doses of 15d-PGJ 2 induced only a slight increase in the osteopontin levels but not statistically significant (Fig. 5C, p > 0.05) . Also, as demonstrated in Fig. 6 , the RUNX mRNA was up-regulated in the presence of 15d-PGJ 2 , although only the dose of 3 μM showed statistical difference (p b 0.05).
Since the osteoblastic cells are an important source of bone metabolic molecules, such as RANKL and OPG, the expression of these proteins was evaluated in these cells under 15d-PGJ 2 supplementation.
Interestingly, after 72 h in the presence of 15d-PGJ 2 , it was observed a tendency to decrease the RANKL expression, mainly at the lower doses, by osteoblast cells, although no statistical significance was detected (Fig. 7A) . On the other hand, the OPG expression had slightly increased in the presence of 15d-PGJ 2 but not statistically significant (Fig. 7B) .
As observed in Fig. 8 , neither the cytosolic PPAR-γ (A) nor nuclear PPAR-γ (B) expression was significantly increased in the presence of different doses of 15d-PGJ 2 . On the other hand, the HDAC-9c has statistically significant increased (p b 0.05) at doses of 3 μM in comparison to control (Fig. 8C) .
Discussion
It is consensus that PPAR-γ plays an important role in skeletal metabolism. Specifically, PPAR-γ haplo-deficient mice exhibit increased bone mass associated with increased osteoblastogenesis and decreased adipogenesis [17] . Therefore, increased PPAR-γ activation may contribute to the reduced osteoblast production and bone loss that occurs with aging [18] . On the other hand, the 15d-PGJ 2 that is an endogenous molecule that may bind to PPAR-γ, is generated in response to tissue injury [19, 20] during the resolution phase of inflammation [21] , and has been demonstrated as an excellent anti-inflammatory drug when exogenously administrated [10, 12, 22, 23] . In the present study it was demonstrated that low doses of 15d-PGJ 2 improve the osteoblast activity in a PPAR-γ-independent manner due to, at least in part, to the elevated expression of Histone Deacetylase 9c (HDAC-9c).
Using murine marrow-derived mesenchymal cells, as well as a model marrow-derived stromal cell line over-expressing PPAR-γ2, it was shown that activation of PPAR-γ2 with rosiglitazone and, in a lesser extent 15d-PGJ 2 , stimulates adipogenesis and inhibits osteoblastogenesis in U33/γ2 cells [7] . Compared with rosiglitazone, the degree of maximal adipogenesis stimulation achieved by 15dPGJ 2 , 9-HODE, and 9,10-DHOA was significantly lower [7] .
MC3T3-E1 cell line, derived from newborn mouse calvaria, is considered a good model for studying osteoblasts differentiation, particularly extracellular matrix signaling after growth in ascorbic acid and inorganic phosphate medium [24] . Our results are consistent with the literature, which demonstrated collagen fibrils formation followed by nodules matrix formation [25] . As a pre-requisite of the onset of mineralization, osteopontin and osteonectin were detected indicating maturation of the osteoblasts [26] . Therefore, the presence of lower doses of 15d-PGJ 2 clearly favored osteoblast cells to produce osteonectin and type I collagen, as well as to deposit mineral nodules. After the early stages of cell culture, osteoblasts synthesize the extracellular matrix, followed by activation of bone differentiation markers in a well-known temporal sequence [27] . Considering this, type I collagen is essential for induction of osteoblasts differentiation markers, such as bone sialoprotein protein, osteonectin and osteopontin [28] [29] [30] . Thus, our results have demonstrated that 15d-PGJ 2 supplementation did not affect osteoblasts differentiation, and also lower doses of 15d-PGJ 2 contributed for increased bone-related proteins expression.
15d-PGJ 2 is generated as a consequence of dehydration of PGD 2 , a principal COX-2 product formed in various cells and tissues during the inflammatory processes [31] . PGD 2 is spontaneously converted into prostaglandin J 2 (PGJ 2 ), which undergoes intramolecular rearrangement of the 13,14-double bond followed by dehydration to form 15d-PGJ 2 [32] . The electrophilic α,β-unsaturated carbonyl group present in its cyclopentenone ring allow the interaction with critical cellular nucleophiles. Several of the biological effects elicited by 15d-PGJ 2 are mediated by modulating the activities of some key transcription factors, such as nuclear factor-kappaB (NF-kB), signal transducers and activators of transcription 3 (STAT3), nuclear factor-erythroid 2p45 (NF-E2)-related factor (Nrf2), activator protein-1 (AP-1), hypoxia inducible factor, p53, thioredoxin [33] . Moreover, the modulation of the transcription factors and other signaling molecules by 15d-PGJ 2 is not necessarily mediated via PPAR-γ activation [32] . Our data has also demonstrated that among the low doses used, the PPAR-γ expression was not up-regulated in contrast to HDAC-9c. This is an important observation that may explain the absence of increased PPAR-γ levels under the influence of 15d-PGJ 2 .
The acetylation of histone proteins, loosens the structure of the target gene promoter and results in increased accessibility for transcription factors and RNA polymerase II, thus initiating transcription. Conversely, deacetylation of histone proteins mediated by histone deacetylases, promotes formation of a compact chromatin structure and repression of transcription [34] . Several anti-inflammatory drugs, as well as the immunosuppressive cytokine transforming growth factor-β1 (TGF-β1), have been demonstrated to induce the recruitment of HDACs to specific gene promoters for silencing gene expression [35, 36] . It has been previously demonstrated that HDAC-9c plays a crucial role in the acceleration of mesenchymal stem cells (MSC) osteogenesis and attenuation of MSC adipogenesis through interaction with PPARγ-2, which interrupts PPARγ-2 transcriptional activity resulting in attenuation of adipogenesis and acceleration of osteogenesis [37] . This observation may explain our results once in the presence of low doses of 15d-PGJ 2 (mainly 3 μM) we did not observe an increased expression of the PPAR-γ in contrast to HDAC-9c over-expression probably modulating the PPAR-γ activity. Moreover, previous data has also demonstrated that 15d-PGJ 2 inhibit IL-1β-induced COX-2 expression by interfering with histone acetylase p300 [38] .
Altogether our results demonstrated that 15d-PGJ 2 at small doses favored the osteoblast activity and the bone-related proteins expression in a PPAR-γ-independent manner.
